AC Health, the healthcare arm of the Ayala Group, is targeting to grow into a $2-billion healthcare enterprise by 2035 by expanding its businesses through acquisitions and organic growth.
During the Ayala Corporation annual stockholders’ meeting, AC Health President and CEO Paolo Borromeo expounded the company’s long-term goals, highlighting its first 10 years of strategic expansion and operational integration across its ecosystem.
“What we’re building is a healthcare group designed for the long haul. We are backed by an ecosystem that is rooted in our commitment to providing quality, accessible healthcare for every Filipino,” he said.
To achieve its 2035 ambition, AC Health will continue to deepen and expand its presence in key cities through organic and inorganic expansion of its hospital and clinic network. The company will also expand its retail pharma presence nationwide through a multi-brand retail approach.
“Our long-term ambition is clear, to serve one in every five Filipinos by 2030. In fact, in the next three years alone, we aim to expand our pharmacies from 880 to 1,150 retail drugstores, our clinics from 236 to over 300 clinics, and our hospitals from six to 10 in major cities,” said Borromeo.
He noted that, with their target of becoming a $2 billion company in the next 10 years, they will have to expand the capacity of their hospitals to about 3,000 to 4,000 beds from the current 800 beds in its system.
AC Health is currently in negotiations for the acquisition of seven to 10 hospitals with capacities of between 100 and 200 beds located in major cities nationwide.
“Our goal is to build a healthcare company that is not only financially resilient, but also deeply transformative for Filipinos,” Borromeo said.
He added that, “We want to be a key contributor to Ayala's legacy, not just in terms of bottom line, but in the real difference we make in people's lives. And we'll get there step by step, patient by patient, community by community.”
From its first investment in Generika Drugstore in 2015, AC Health has grown into a robust and integrated network that now includes 236 corporate and multispecialty clinics, six hospitals under Healthway Medical Network, 880 pharmacies between Generika Drugstore and St. Joseph Drug, and 1,178 certificates of product registration under I.E. Medica and MedEthix
In 2024, AC Health’s revenues grew 10 percent to ₱9.4 billion. Its provider group under Healthway Medical Network saw a revenue growth of 22 percent, which was well above the hospital industry growth of eight percent.
Meanwhile, revenue from its pharma group outperformed the pharma industry, which experienced a five percent decline.
Borromeo said all of AC Health’s business units are already profitable except for its cancer care center.